Medicines etiketine sahip kayıtlar gösteriliyor. Tüm kayıtları göster
Medicines etiketine sahip kayıtlar gösteriliyor. Tüm kayıtları göster

13 Şubat 2017 Pazartesi

Unproven alternative medicines recommended by third of Australian pharmacists

Nearly one third of pharmacists are recommending complementary and alternative medicines with little-to-no evidence for their efficacy, including useless homeopathic products and potentially harmful herbal products.


The finding comes from a Choice survey of 240 pharmacies including Priceline, Chemist Warehouse and Terry White. Mystery shoppers were sent in to speak to a pharmacist at the prescription dispensing counter and ask for advice about feeling stressed.


Three per cent of the pharmacists recommended homeopathic products, despite a comprehensive review of all existing studies on homeopathy finding that there is no evidence they work in treating any condition.


Twenty-six percent recommended Bach flower remedies to shoppers, homeopathic solutions of alcohol and water containing diluted flower essences. The solution was invened by a British homeopath, Edward Bach, who claimed to have a psychic connection to plants. A comprehensive review of all existing studies on Bach flower solutions found no difference between the remedies and placebos.


The Choice survey also found products containing a B group vitamin complex were recommended by pharmacists for stress in 46% of cases. Other frequently recommended products were St John’s wort and valerian. There is no good evidence that these products reduce stress.


Fifty-nine per cent of people were just told the complementary and alternative product recommended to them worked, and 24% were told the product was scientifically proven, without any evidence being provided to them, the survey found.


A prominent public health expert and the director of Medreach, Dr Ken Harvey, famously quit his job as an adjunct professor with Victoria’s La Trobe University in 2014 after the university struck a $ 15m, six-year deal with vitamins manufacturer Swisse.


He said the Choice survey demonstrated that some pharmacists were failing in their professional duty to consumers.


“Pharmacists are giving crazy advice, and it is dangerous in some cases,” he said.


“My view is that pharmacists, if they are going to sell these products, need to have a big shining sign over the shelves of the complementary and alternative medicine section that says ‘these products have not been assessed by the government regulators to see if they work, please talk to pharmacist’.


Harvey said it was not uncommon for manufacturers of complementary and alternative medicines to do deals with pharmacists so that when customers filled a script for a prescription medicine, the pharmacist would recommend a “front of shop” product to “complement” the prescription medication.


“Pharamacists are giving poor advice and they clearly have a conflict of interest,” Harvey said.


“There is no doubt about that companies. Vitamin companies come into their stores and stick their products on the shelves and provide the pharmacist with posters and pamphlets, and the pharmacists wash their hands of it. But they’re abdicating their professional responsibilities.”


National president of the Pharmacy Guild, George Tambassis, said people trusted pharmacists, and therefore they had a duty-of-care to be aware of available clinical evidence about the therapeutic and marketing claims made about products sold in their stores.


In a statement, the Guild said it was “essential that consumers have access to objective, informed advice about complementary medicines, and by far the best place to obtain that advice is at a community pharmacy”.


Pharmacology lecturer Ian Musgrave from the University of Adelaide said while he expected shop assistants might not be up to date with the latest evidence for complementary and alternative products, he expected better from pharmacists, who have at least four years of university education.


“I would suggest that we need more education, potentially post-graduate education, on herbals and complementary medicines, especially seeing as now a number of pharmacies have a substantial section with these products,” he said.



Unproven alternative medicines recommended by third of Australian pharmacists

16 Aralık 2016 Cuma

Top 10 Medicines Already in Your Spice Rack

Could powerful natural medicine already be in your spice rack right now?
In Western culture, we typically look at our spice rack only as a means to flavor our meals. Elsewhere around the world, however, other cultures have known about the medicinal properties of these spices and have used them as such for thousands of years. “Let thy food be thy medicine, and let thy medicine be thy food.” Those are the famous words from Hippocrates, who figured this out and healed people with these spices thousands of years ago. Let’s take a look at the top 10 medicines already in your spice rack.
1. Turmeric
It is widely known that curcumin, the primary compound in Turmeric that provides therapeutic properties, has anti-inflammatory effects. However, Turmeric’s therapeutic properties don’t stop there. A study conducted at UCLA demonstrated that amyloid plaques found in Alzheimer’s disease could be cleared with curcumin. Further evidence of this is seen in the research indicating a lower incidence of Alzheimer’s in India, where 80% of the world’s Turmeric is consumed on a daily basis.


2. Cinnamon
Cinnamon is a warming spice made from the inner bark of several tree species from the genus Cinnamomum. The research indicates that cinnamon has antioxidant, antimicrobial, cholesterol-lowering, anti-tumor, and immune-boosting effects. In vitro studies demonstrated that cinnamon can act as an insulin mimetic, which can boost insulin activity and stimulate glucose metabolism.


3. Clove
Clove is found in the majority of every anti-parasitic formula on the market and for a good reason. Clove can stun and release parasites of all kinds from the body. Parasites can wreak havoc on the body and tissues by depriving you of the nutrients found in the food you eat. Parasites can also influence chemicals in the brain that make you crave sweets/sugar, influencing your habits to get what they want to eat. Clove also has oral hygiene properties to keep bacteria from getting out of hand and is a great adjunct to your oral hygiene protocol.


4. Oregano
Although the oregano in your spice rack is the dried herb, oil of oregano is one of the most powerful antibiotics/antifungals available for athlete’s foot and other persistent chronic infections. A study published in the Journal of Applied Microbiology revealed oil of oregano to be more effective than antifungal drugs in treating Candida albicans, a prominent fungal infection that impairs health and immunity.


5. Garlic
Garlic is one of the most powerful antibiotics found in nature. Garlic has been shown to be therapeutic with cardiovascular problems, cognitive impairments, blood quality, immunological health, and also inflammation. Research published by Cancer Prevention Research outlined the efficacy of garlic to minimize proliferation of esophageal cancer, stomach cancer, prostate cancer, and colorectal cancer. This makes garlic one of the most affordable cancer treatments available, as you can often find it for under a dollar in your produce section.


6. Cayenne
According to the University of Maryland Medical Center, cayenne pepper reduces the amount of substance P, a chemical that carries pain messages to the brain, providing pain relief properties. Cayenne is also effective as a cream to reduce itching and inflammation from psoriasis.


7. Olive Oil
Olive oil, a staple in the Mediterranean diet, has antiviral, antifungal, and antibacterial properties. Illnesses of the heart are lower in the Mediterranean region, and research indicates Olive Oil may be supporting cardiovascular health with its lipid and antioxidant profile. Instances of cancer are also lower in regions where Olive Oil is most consumed and produced.


8. Fennel Seeds
If you’ve ever been to an Indian food restaurant, you’ll notice there is often a little container of fennel seeds near the exit or on the table. The reason is due to Fennel Seed’s ability to work as both a breath freshener and also a digestive aid. Fennel seeds lower excess gas, bloating, and discomfort after eating heavy meals. Fennel seeds also contain nitrates that may be beneficial for the vascular system.


9. Thyme
Thyme is a fragrant herb, and the essential oils that give Thyme its aroma and flavor have been shown to increase healthy fats in cell membranes and cell structures, including the mind-supporting DHA, after consumption. Thyme is also one of the leading antifungal herbs, often being used to keep candida infections under control. The University of Michigan Health System shows Thyme being connected to treatments for lung infections, bacterial infections, lice, halitosis, and indigestion.


10. Ginger
Ginger is a very powerful and diversified medicine in your spice rack. Ginger offers support for digestion, metabolism, infections, flu, common cold, sinus issues, and blood quality. Ginger is also found in the majority of leading inflammation supplements, alongside Turmeric. Additionally, Ginger has been shown to have pain-relieving properties, anticancer properties, and is great for soothing nausea. Ginger completes our list of the Top 10 Medicines Already in Your Spice Rack.


Learn more at http://earthfoods.info and follow Earth Foods on Facebook: http://facebook.com/earthfoods


Sources:


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781139/
https://www.ncbi.nlm.nih.gov/pubmed/20924865
https://www.ncbi.nlm.nih.gov/pubmed/27568869
http://umm.edu/health/medical/altmed/herb/cayenne
http://www.nature.com/ejcn/journal/v57/n1/full/1601497a.html
https://www.ncbi.nlm.nih.gov/pubmed/23240972



Top 10 Medicines Already in Your Spice Rack

17 Ekim 2016 Pazartesi

Looking for non-invasive medical remedies; Try Naturopathic Medicines

Naturopathy is a holistic form of medicine that uses natural and non-toxic therapies to treat illnesses, prevent diseases and improve health. It presents a non-invasive and a complete form of treatment. Discovered in the 1800s naturopathic medicine borrows from a wide array of traditional healing practices; acupuncture, herbalism, botanical medicine and the use of nutritional supplements. Naturopathic medicine  encourages the self-healing process of the body using modern and traditional, empirical and scientific techniques. The treatment works by first finding the cause of the problem, unlike modern medicine that aims at treating the symptoms.


Naturopathic Physicians conduct lengthy interviews with patients focusing on their physical wellbeing, diet, lifestyle and emotional health. As such, they base their treatments on some beliefs:


· The self-healing nature of the body: the body has an innate self-healing ability, and naturopathy only facilitates this process by eliminating any obstacles.


· Use of gentle and non-invasive therapies.


· A holistic approach to treating patients: physicians identify any imbalances in the body and tailor the treatment to rectify it (depending on the symptoms presented).


· Symptoms denote an underlying internal imbalance caused by emotional, physical or mental problems.


· Focus is on proactive prevention: naturopathic physicians believe in preventing rather than treating diseases through an evaluation of subjective and objective information. As such, doctors can quickly decipher any future vulnerability in patients.


Naturopathic medicine is known to deal with all kinds of medical ailments the most common being; chronic pain, cancer, allergies, hormonal imbalances, fibromyalgia, fertility problems, menopause, respiratory conditions among others. In our discussion, we will look at 4-5 cures of using Naturopathic Medicine


1. Naturopathy to treat heart disease


Heart disease is also referred to as cardiovascular or coronary artery disease. Different medicines have been developed to treat the disease but most effective remedy requires diet changes. Naturopathic doctors recommend various natural ways of addressing the problem:


Mediterranean diet: it is a plant-based diet that is rich in fiber, fruits, whole grains and vegetables. It also emphasizes on monosaturated fats like olive oil and foods rich in Omega 3.


Supplements and herbs: they help fight atherosclerosis (the major cause of heart disease). Herbs like Coenzyme Q10 (an antioxidant that aids in energy production), Hawthorn (helps in the relaxation of blood vessels) and Taurine (protects and improves symptoms related to heart failure).


Meditation: it reduces physical, mental and emotional stress correlated with cardiac problems. Naturopathic doctors also recommend adding other forms of relaxation like listening to music, walking, dancing to your daily routine to reduce stress.


2. Naturopathy to treat fibromyalgia


Fibromyalgia is a health condition that causes chronic fatigue, chronic pain, depression, memory problems, irritable bowel syndrome, and headaches. It is a multi-casual health condition that requires a deep understanding of the body organs to treat the multiple factors that initiate the problem. If the multiple stressors occur over an extended period, they cause fibromyalgia, destroying the body’s natural healing ability. The condition requires an integrative approach of treatment i.e. through the use of conventional and alternative diagnostic techniques like naturopathy. Naturopathy physicians recommend the following therapies for patients suffering from fibromyalgia:


· Gentle exercises like yoga, dancing, Tai Chi, and walking.


· Eating foods rich in minerals like potassium citrate and magnesium maltase.


· Eating foods rich in anti-inflammatory and digestive enzymes.


· Foods that contain anti-oxidant vitamins like Beta-carotene, B-complex, C and E.


· Adding foods rich in fatty acids to your diet; fish oils, flaxseed oil, and primrose oil.


· Detoxification program that includes liver cleansing, mercury detoxification and amalgam removal.


3. Naturopathy to treat chronic pain


Chronic pain is pain that lasts longer than six months. The pain can be mild, excruciating or in the form of sporadic episodes. The most common causes of chronic pain include headaches, backaches, joint pain, and pain from an injury. Other kinds of chronic pain include pain affecting certain parts of the body such as the leg, neck, arm, shoulders, and the pelvis. It may also originate with an infection or initial trauma. Physicians recommend various medicines to treat/relieve chronic pain but most of them offer modest results and cause a host of side effects.


Naturopathy provides a more holistic alternative of treating chronic pain with or without cause by identifying imbalances in the body that irritate tissues, or nerves causing pain. For example if the pain occurs on both sides of the body, it indicates an underlying disorder; if it occurs on one location it is more likely to be caused by an injury. Naturopathic medicine provides various solutions for treating pain:


Acupuncture: it relieves pain by helping the body to release endorphins, reduce pain signals to the brain and stimulate the body’s healing ability.


An anti-inflammation diet: naturopathic physicians prescribe herbal medicines that reduce inflammation.


Hydrotherapy: here water is used to increase circulation, reduce inflammation and promote detoxification thus managing chronic pain.


Supplementation: natural supplements like curcumin, and fish oils reduce inflammation, muscle tension without causing adverse side effects.


4. Naturopathy to treat fertility problems


Infertility is a health problem affecting both men and women. Studies show 30% of infertility problems are caused by female factors, 30% due to male factors and 40% due to unknown causes. Modern medical diagnosis and remedies involve lots of invasive tests, surgery, drug therapy and now artificial conception technology.


Naturopathic therapy, on the other hand, provides a more holistic view of treating infertility problems. The couple is treated individually while addressing their emotional, spiritual and psychological aspects. Some naturopathic remedies used include herbalism, making nutritional adjustments, flower essences (helps relax the mind), osteopathy and homeopathy. The treatments enhance the body’s natural processes without the use of invasive surgical methods, artificial conception technologies or toxic drugs.


5. Naturopathy to treat allergies


An allergy is an aggressive immune response triggered by inhaling irritants like pollen or ingesting certain kinds of foods. People suffering from allergies are sensitive to mold, dust, spores, and pollen. Naturopathic medicine  associates allergies with weak immune and digestive functions thus naturopathic remedies help improve their function and eliminate the symptoms. Patients suffering from seasonal allergies should start the natural therapies a month or two before the season commences to minimize the severity of the symptoms. Other naturopathic remedies include:


· Herbal medicines like Dong Quai (has anti-inflammatory properties), eyebright (ideal for sneezing and itchy eyes), and the red clover (enhances the body’s resistance to allergies). Patients may make a tea of one or more herbs.


· Nutrition: include dark green, leafy veggies, deep yellow veggies, carrots, yams cabbage, ginger, onions and garlic.


· Hydrotherapy; hot foot baths, castor oil packs and placing a cold cloth on the forehead.


Sources


www.cancercenter.com


www.naturopathic.org


activebacktohealth.com


www.thehealthsite.com



Looking for non-invasive medical remedies; Try Naturopathic Medicines

Looking for non-invasive medical remedies; Try Naturopathic Medicines

Naturopathy is a holistic form of medicine that uses natural and non-toxic therapies to treat illnesses, prevent diseases and improve health. It presents a non-invasive and a complete form of treatment. Discovered in the 1800s naturopathic medicine borrows from a wide array of traditional healing practices; acupuncture, herbalism, botanical medicine and the use of nutritional supplements. Naturopathic medicine  encourages the self-healing process of the body using modern and traditional, empirical and scientific techniques. The treatment works by first finding the cause of the problem, unlike modern medicine that aims at treating the symptoms.


Naturopathic Physicians conduct lengthy interviews with patients focusing on their physical wellbeing, diet, lifestyle and emotional health. As such, they base their treatments on some beliefs:


· The self-healing nature of the body: the body has an innate self-healing ability, and naturopathy only facilitates this process by eliminating any obstacles.


· Use of gentle and non-invasive therapies.


· A holistic approach to treating patients: physicians identify any imbalances in the body and tailor the treatment to rectify it (depending on the symptoms presented).


· Symptoms denote an underlying internal imbalance caused by emotional, physical or mental problems.


· Focus is on proactive prevention: naturopathic physicians believe in preventing rather than treating diseases through an evaluation of subjective and objective information. As such, doctors can quickly decipher any future vulnerability in patients.


Naturopathic medicine is known to deal with all kinds of medical ailments the most common being; chronic pain, cancer, allergies, hormonal imbalances, fibromyalgia, fertility problems, menopause, respiratory conditions among others. In our discussion, we will look at 4-5 cures of using Naturopathic Medicine


1. Naturopathy to treat heart disease


Heart disease is also referred to as cardiovascular or coronary artery disease. Different medicines have been developed to treat the disease but most effective remedy requires diet changes. Naturopathic doctors recommend various natural ways of addressing the problem:


Mediterranean diet: it is a plant-based diet that is rich in fiber, fruits, whole grains and vegetables. It also emphasizes on monosaturated fats like olive oil and foods rich in Omega 3.


Supplements and herbs: they help fight atherosclerosis (the major cause of heart disease). Herbs like Coenzyme Q10 (an antioxidant that aids in energy production), Hawthorn (helps in the relaxation of blood vessels) and Taurine (protects and improves symptoms related to heart failure).


Meditation: it reduces physical, mental and emotional stress correlated with cardiac problems. Naturopathic doctors also recommend adding other forms of relaxation like listening to music, walking, dancing to your daily routine to reduce stress.


2. Naturopathy to treat fibromyalgia


Fibromyalgia is a health condition that causes chronic fatigue, chronic pain, depression, memory problems, irritable bowel syndrome, and headaches. It is a multi-casual health condition that requires a deep understanding of the body organs to treat the multiple factors that initiate the problem. If the multiple stressors occur over an extended period, they cause fibromyalgia, destroying the body’s natural healing ability. The condition requires an integrative approach of treatment i.e. through the use of conventional and alternative diagnostic techniques like naturopathy. Naturopathy physicians recommend the following therapies for patients suffering from fibromyalgia:


· Gentle exercises like yoga, dancing, Tai Chi, and walking.


· Eating foods rich in minerals like potassium citrate and magnesium maltase.


· Eating foods rich in anti-inflammatory and digestive enzymes.


· Foods that contain anti-oxidant vitamins like Beta-carotene, B-complex, C and E.


· Adding foods rich in fatty acids to your diet; fish oils, flaxseed oil, and primrose oil.


· Detoxification program that includes liver cleansing, mercury detoxification and amalgam removal.


3. Naturopathy to treat chronic pain


Chronic pain is pain that lasts longer than six months. The pain can be mild, excruciating or in the form of sporadic episodes. The most common causes of chronic pain include headaches, backaches, joint pain, and pain from an injury. Other kinds of chronic pain include pain affecting certain parts of the body such as the leg, neck, arm, shoulders, and the pelvis. It may also originate with an infection or initial trauma. Physicians recommend various medicines to treat/relieve chronic pain but most of them offer modest results and cause a host of side effects.


Naturopathy provides a more holistic alternative of treating chronic pain with or without cause by identifying imbalances in the body that irritate tissues, or nerves causing pain. For example if the pain occurs on both sides of the body, it indicates an underlying disorder; if it occurs on one location it is more likely to be caused by an injury. Naturopathic medicine provides various solutions for treating pain:


Acupuncture: it relieves pain by helping the body to release endorphins, reduce pain signals to the brain and stimulate the body’s healing ability.


An anti-inflammation diet: naturopathic physicians prescribe herbal medicines that reduce inflammation.


Hydrotherapy: here water is used to increase circulation, reduce inflammation and promote detoxification thus managing chronic pain.


Supplementation: natural supplements like curcumin, and fish oils reduce inflammation, muscle tension without causing adverse side effects.


4. Naturopathy to treat fertility problems


Infertility is a health problem affecting both men and women. Studies show 30% of infertility problems are caused by female factors, 30% due to male factors and 40% due to unknown causes. Modern medical diagnosis and remedies involve lots of invasive tests, surgery, drug therapy and now artificial conception technology.


Naturopathic therapy, on the other hand, provides a more holistic view of treating infertility problems. The couple is treated individually while addressing their emotional, spiritual and psychological aspects. Some naturopathic remedies used include herbalism, making nutritional adjustments, flower essences (helps relax the mind), osteopathy and homeopathy. The treatments enhance the body’s natural processes without the use of invasive surgical methods, artificial conception technologies or toxic drugs.


5. Naturopathy to treat allergies


An allergy is an aggressive immune response triggered by inhaling irritants like pollen or ingesting certain kinds of foods. People suffering from allergies are sensitive to mold, dust, spores, and pollen. Naturopathic medicine  associates allergies with weak immune and digestive functions thus naturopathic remedies help improve their function and eliminate the symptoms. Patients suffering from seasonal allergies should start the natural therapies a month or two before the season commences to minimize the severity of the symptoms. Other naturopathic remedies include:


· Herbal medicines like Dong Quai (has anti-inflammatory properties), eyebright (ideal for sneezing and itchy eyes), and the red clover (enhances the body’s resistance to allergies). Patients may make a tea of one or more herbs.


· Nutrition: include dark green, leafy veggies, deep yellow veggies, carrots, yams cabbage, ginger, onions and garlic.


· Hydrotherapy; hot foot baths, castor oil packs and placing a cold cloth on the forehead.


Sources


www.cancercenter.com


www.naturopathic.org


activebacktohealth.com


www.thehealthsite.com



Looking for non-invasive medical remedies; Try Naturopathic Medicines

26 Ocak 2015 Pazartesi

Hayfever medicines raise chance of Alzheimer"s disease, say scientists


In excess of-the counter hayfever tables, sleeping pills or asthma drugs drastically increase the chance of establishing dementia, a study has shown.




Taking a everyday dose of capsules like Benadryl, Piriton and Nytol, for at least 3 many years, can improve the possibility of obtaining Alzheimer’s condition by a lot more than 60 per cent.




Researchers at the University of Washington stated pensioners taking over-the-counter drugs must tell their physicians and end taking medicine instantly if it is not needed.




The drugs are identified as ‘anticholinergics’ which operate by blocking acetylcholine, a chemical involved in the transmission of electrical impulses among nerve cells. People with Alzheimer’s disease are acknowledged to lack acetylcholine and it is feared the pills might exacerbate or set off the situation.




Other medication on the risk-record include older antidepressants such as doxepin, and the bladder manage treatment method Ditropan.





Numerous of these medicines are taken by vulnerable older folks, according to the scientists, who say their findings have public wellness implications.


“Older grownups must be aware that numerous medicines – like some available with out a prescription, such as above-the-counter rest aids – have robust anticholinergic results. And they must inform their overall health-care companies about all their in excess of-the-counter use,” stated US research leader Professor Shelly Gray, director of the geriatric pharmacy system at the University of Washington College of Pharmacy.


“Of program, no a single need to end taking any treatment without consulting their wellness-care supplier.


“Health-care providers should often evaluation their older patients’ drug regimens – such as over-the-counter drugs – to appear for chances to use fewer anticholinergic prescription drugs at lower doses.”


Prior investigation has raised issues about the use of anticholinergic medicines and psychological impairment in the elderly.


But the new review, published in the journal Jama Internal Medicine, is the first to show a dose response linking greater use of the medicines with an escalating chance of dementia.


The scientists tracked the wellness of 3,434 guys and ladies aged 65 and over for around seven many years even though monitoring their use of anticholinergic medication.


Of the total, 637 created Alzheimer’s disease and 160 other types of dementia.


For individuals taking the highest doses of anticholinergic medicines in excess of the research time period, the relative threat of dementia was enhanced by a statistically important 54 per cent in contrast with no use. The danger of Alzheimer’s alone was raised by 63 per cent.


The findings showed that men and women taking at least 10 milligrams per day of doxepin, four milligrams per day of diphenhydramine (Nytol, Benadryl) or 5 milligrams per day of oxybutynin (Ditropan) for a lot more than three years would have an enhanced chance of creating dementia.


Accessible substitutes that did not have anticholinergic results incorporated selective serotonin re-uptake inhibitor (SSRI) antidepressants this kind of as Prozac and newer anti-histamine allergy remedies which includes loratadine (Claritin), said Prof Gray.


“If providers need to have to prescribe a medicine with anticholinergic results since it is the very best therapy for their patient, they need to use the lowest effective dose, keep track of the treatment routinely to make sure it is operating, and cease the treatment if it truly is ineffective,” additional Professor Gray.


Earlier investigation has identified that anticholinergic results in animals had been shown to improve levels of beta-amyloid protein in the brain, one particular of the hallmarks of Alzheimer’s.


The authors conclude: “These findings .. have public wellness implications for the education of older grownups about possible security risks because some anticholinergics are obtainable as above-the-counter items.


“Given the devastating consequences of dementia, informing older adults about this probably modifiable risk would allow them to choose different items and collaborate with their overall health care specialists to minimise total anticholinergic use.


“Added scientific studies are essential to verify these findings and to understand the underlying mechanisms.”


Charities explained that elderly folks need to seek suggestions from their medical professionals prior to stopping their medication.


Dr Simon Ridley, Head of Investigation at Alzheimer’s Analysis United kingdom, the UK’s major dementia analysis charity, stated: “This large research adds to some current proof linking anticholinergic medicines to a modest increased chance of dementia, but the results really don’t inform us that these medicines trigger the condition. Continued investigation to shed light on these links will be crucial for assisting realize the positive aspects and prospective hazards of these drugs.


“In the meantime, any person who is concerned about the medication they are taking need to look for guidance from a medical professional or pharmacist before stopping a course of remedy. Investment in investigation is essential if we are to discover far more efficient approaches of treating and avoiding dementia.”





Hayfever medicines raise chance of Alzheimer"s disease, say scientists

18 Temmuz 2014 Cuma

Breakthrough created in quest for new malaria medicines as resistance fears expand

Australian researchers have created a significant breakthrough in the race to discover new medicines to eliminate malaria, as resistance increases to the only drug left to treat the ailment.


Scientists from the Burnet Institute, Deakin University and Monash University were in a position to starve the malaria parasite of crucial proteins important to its survival, delivering a target for the improvement of new antimalarial drugs.


The malaria parasite exists inside a red blood cell – which permits it to go undetected by the immune technique, but is not an excellent atmosphere for the parasite to expand and thrive.


A co-writer of the paper, published in Nature, Tania de Koning-Ward from Deakin’s medical school, stated it meant the parasite had to “renovate” its setting by sending hundreds of its own proteins into the red blood cell for it to feed on.


“What our study has proven is individuals proteins can only get accessibility to the red blood cell via one gateway, which provides a channel for the proteins to get into the red blood cell so that it can reside and multiply,” she explained.


“We managed to alter the perform of this gateway so that these proteins can no longer get into the red blood cells, starving and killing the parasite.”


In 2009 researchers first discovered the malaria parasite obtained the proteins it essential by means of a gateway. But they were unsure whether blocking that gateway meant the parasite would basically uncover one more one. Parasites are notoriously great at adapting.


That meant convincing drug companies to invest in establishing medication to block the gateway had been a hard sell till now, De Koning-Ward explained.


“What we have shown by way of this analysis is the parasite utilizes just this a single gateway to acquire these proteins, which makes that gateway a excellent target for drug therapies.”


As parasites create resistance to drugs, researchers usually tweak them slightly to make them tougher for the parasite to battle. But the parasite often speedily develops resistance to the newer versions.


Artemisinin – the only drug left to deal with malaria – and the drug that came just before it, chloroquine, the two worked by offering the malaria parasite what was primarily a negative situation of indigestion, avoiding it from being able to eradicate a construct-up of iron that takes place right after it ingests haemoglobin.


Another co-author of the review, Dr Paul Gilson, senior investigation officer at Burnet Institute, stated the new research meant drug firms could now change their tactic totally. Alternatively of blocking the parasite’s capacity to detoxify the iron ingested, they could target the gateway it employed to get the “food”.


“It implies that when a drug that blocks the gateway is created, it may possibly get a whole lot longer for the malaria parasite to develop resistance to it, since it will never ever have witnessed a drug like this just before,” he said.


Resistance to artemisinin has previously occurred in parts of south-east Asia.


Gilson believes medicines that target the gateway could be prepared inside a few years, but explained they would then want to undergo trials that could get up to an additional ten many years.


“But the cupboard of medication obtainable to treat malaria is at present quite bare,” Gilson stated. “Our study supplies an critical new target for drug development.”


Malaria is spread via mosquitoes and its most lethal form is caused by the parasite plasmodium falciparum. More than 200 million people get malaria each and every 12 months and far more than half a million of those, mostly young children, die from the illness.


The speedy development in population movements meant there was a chance resistant malaria might reach other countries more speedily, Gilson explained. Whilst resistant malaria is not impossible to treat, it takes a whole lot longer.



Breakthrough created in quest for new malaria medicines as resistance fears expand

17 Temmuz 2014 Perşembe

NHS medicines watchdog lowers bar for statins prescriptions

Statin pills

Statin tablets. Photograph: Alamy




About 40% of the grownup population could be supplied cholesterol-busting statins medication by their medical doctors, below official advice from the NHS medicines watchdog.


The National Institute for Health and Clinical Excellence (Good) confirmed the draft recommendation it produced in February, which sparked a row among doctors in excess of alleged above-prescribing. Some critics accused Nice’s guideline group of shut ties with the pharmaceutical business.


Prof Mark Baker, director of the centre for clinical practice at Good, strongly defended both the choice to provide the medicines to people with a lower danger of heart condition than previously suggested and the independence of people doing work on the guideline. They had carried out their operate “in the face of some entirely unjustified attacks on their integrity,” he explained.


“I have to remind you that no one will get into our tips group if they have any considerable vested interest, particularly a financial interest,” he explained at the launch of the guideline on tackling the threat of heart attacks and strokes. All the interests of the group members were declared, not like people of some of the critics, he explained. Appointees to the group are essential to have had no economic involvement with pharmaceutical businesses for at least the prior year.


Great says GPs should first talk about life-style measures – a better diet program and much more exercise – with men and women who have a ten% risk of a heart attack or stroke in the subsequent ten years. They can then supply a statin if they believe it appropriate. Previously, GPs have been suggested to intervene when their patient had a twenty% risk.


An estimated four.five million much more individuals will be eligible for statins, in addition to the 13 million presently eligible. Great says half these patients will possibly not be presented them or will refuse. Somewhere amongst 5 and 10 million are believed to be taking the drugs at present.


The medication are now off-patent and for that reason cheap. Great says if 80% of the 4.five million newly eligible take them, the cost to the NHS will be £52m, which is tiny in the context of the cost savings from heart assault and stroke treatment method.


If two million – significantly less than half – of the decrease-threat group accept statins, Nice estimates that an additional four,000 deaths from heart attacks will be saved, and eight,000 strokes and 14,000 non-fatal heart attacks prevented.


Critics of statins have contested their rewards in individuals at reduced risk and raised considerations about side-results. Baker rejected these arguments. The evidence from randomised, managed trials of the medication “demonstrate the very same frequency and severity of signs in the statins and the placebo group,” he explained.


“Most of the side-results attributed to the medication but not always brought on by them are very typical. The occurrence of issues like muscle ache has minor or nothing to do with whether folks consider statins.”


A single extreme sort of muscle pain had been reported, but it was very unusual, he explained. He believed that some sufferers and GPs had wrongly assumed the significant response was as common as the mild one particular.


Opposition to statins for the decrease-threat group surfaced in the British Health-related Journal last year. The journal has retracted statements in two papers it published. Independent professionals have been asked by the BMJ’s editor, Dr Fiona Godlee, to advise on whether the papers ought to be retracted, in response to a contact from Professor Rory Collins, joint head of the clinical trials support unit at Oxford University.


Nice’s guidance was welcomed by numerous senior scientists, but some pointed out the importance of attempting to modify people’s life style in preference to handing out medicines. “We must not basically use pharmaceuticals to treat the benefits of unhealthy conditions,” mentioned Sir Michael Marmot, director of the Institute of Health Equity at UCL. “Choosing healthier lifestyles is a lot more challenging simply because our society promotes low cost unhealthy meals, lower alcohol costs, and vehicle use rather of walking or cycling.”




NHS medicines watchdog lowers bar for statins prescriptions

Breakthrough made in quest for new malaria medicines as resistance fears expand

Australian researchers have created a significant breakthrough in the race to discover new medicines to remove malaria, as resistance increases to the only drug left to deal with the disease.


Scientists from the Burnet Institute, Deakin University and Monash University were ready to starve the malaria parasite of essential proteins important to its survival, offering a target for the growth of new antimalarial medication.


The malaria parasite exists within a red blood cell – which enables it to go undetected by the immune program, but is not an excellent setting for the parasite to grow and thrive.


A co-writer of the paper, published in Nature, Tania de Koning-Ward from Deakin’s medical school, said it meant the parasite had to “renovate” its environment by sending hundreds of its own proteins into the red blood cell for it to feed on.


“What our analysis has proven is those proteins can only get access to the red blood cell via a single gateway, which supplies a channel for the proteins to get into the red blood cell so that it can live and multiply,” she mentioned.


“We managed to alter the perform of this gateway so that these proteins can no longer get into the red blood cells, starving and killing the parasite.”


In 2009 researchers initial found the malaria parasite obtained the proteins it necessary via a gateway. But they have been uncertain regardless of whether blocking that gateway meant the parasite would merely uncover another one particular. Parasites are notoriously great at adapting.


That meant convincing drug organizations to invest in establishing drugs to block the gateway had been a difficult sell right up until now, De Koning-Ward stated.


“What we have proven via this investigation is the parasite utilizes just this one gateway to obtain these proteins, which helps make that gateway a excellent target for drug remedies.”


As parasites build resistance to medication, researchers usually tweak them somewhat to make them more difficult for the parasite to battle. But the parasite typically quickly develops resistance to the newer versions.


Artemisinin – the only drug left to treat malaria – and the drug that came prior to it, chloroquine, both worked by providing the malaria parasite what was primarily a poor case of indigestion, stopping it from currently being in a position to remove a develop-up of iron that happens soon after it ingests haemoglobin.


Yet another co-writer of the review, Dr Paul Gilson, senior research officer at Burnet Institute, stated the new analysis meant drug companies could now alter their tactic entirely. Rather of blocking the parasite’s capability to detoxify the iron ingested, they could target the gateway it utilized to get the “food”.


“It indicates that when a drug that blocks the gateway is developed, it could get a good deal longer for the malaria parasite to develop resistance to it, due to the fact it will never have noticed a drug like this ahead of,” he stated.


Resistance to artemisinin has presently occurred in elements of south-east Asia.


Gilson believes drugs that target the gateway could be ready inside a few years, but explained they would then need to undergo trials that could take up to another 10 many years.


“But the cupboard of medicines offered to deal with malaria is at the moment rather bare,” Gilson said. “Our investigation provides an essential new emphasis for drug development.”


Malaria is spread through mosquitoes and its most lethal kind is induced by the parasite plasmodium falciparum. Far more than 200 million people get malaria every year and more than half a million of those, mostly youngsters, die from the illness.


The quick development in population movements meant there was a risk resistant malaria may possibly attain other nations more swiftly, Gilson explained. Even though resistant malaria is not unattainable to deal with, it takes a great deal longer.



Breakthrough made in quest for new malaria medicines as resistance fears expand

16 Temmuz 2014 Çarşamba

Breakthrough produced in quest for new malaria medicines as resistance fears expand

Australian researchers have manufactured a main breakthrough in the race to uncover new medicines to remove malaria, as resistance increases to the only drug left to deal with the condition.


Scientists from the Burnet Institute, Deakin University and Monash University had been in a position to starve the malaria parasite of crucial proteins vital to its survival, supplying a target for the growth of new antimalarial medicines.


The malaria parasite exists within a red blood cell – which permits it to go undetected by the immune program, but is not an best environment for the parasite to grow and thrive.


A co-writer of the paper, published in Nature, Tania de Koning-Ward from Deakin’s health-related college, mentioned it meant the parasite had to “renovate” its setting by sending hundreds of its own proteins into the red blood cell for it to feed on.


“What our analysis has proven is people proteins can only get entry to the red blood cell by means of 1 gateway, which offers a channel for the proteins to get into the red blood cell so that it can dwell and multiply,” she explained.


“We managed to alter the perform of this gateway so that these proteins can no longer get into the red blood cells, starving and killing the parasite.”


In 2009 researchers first discovered the malaria parasite obtained the proteins it needed via a gateway. But they have been uncertain regardless of whether blocking that gateway meant the parasite would just uncover an additional one. Parasites are notoriously excellent at adapting.


That meant convincing drug businesses to invest in developing medication to block the gateway had been a challenging sell until finally now, De Koning-Ward mentioned.


“What we have shown through this analysis is the parasite makes use of just this a single gateway to obtain these proteins, which makes that gateway a fantastic target for drug treatment options.”


As parasites develop resistance to drugs, researchers usually tweak them slightly to make them harder for the parasite to battle. But the parasite usually swiftly develops resistance to the newer versions.


Artemisinin – the only drug left to deal with malaria – and the drug that came prior to it, chloroquine, the two worked by offering the malaria parasite what was in essence a bad situation of indigestion, avoiding it from being ready to eliminate a build-up of iron that occurs following it ingests haemoglobin.


Another co-author of the review, Dr Paul Gilson, senior study officer at Burnet Institute, mentioned the new research meant drug firms could now adjust their tactic completely. As an alternative of blocking the parasite’s capacity to detoxify the iron ingested, they could target the gateway it utilized to get the “food”.


“It signifies that when a drug that blocks the gateway is produced, it may take a good deal longer for the malaria parasite to develop resistance to it, simply because it will in no way have observed a drug like this prior to,” he mentioned.


Resistance to artemisinin has previously occurred in parts of south-east Asia.


Gilson believes medicines that target the gateway could be ready inside of a couple of years, but stated they would then want to undergo trials that could take up to yet another ten many years.


“But the cupboard of drugs offered to deal with malaria is currently rather bare,” Gilson said. “Our study supplies an important new concentrate for drug development.”


Malaria is spread through mosquitoes and its most lethal form is induced by the parasite plasmodium falciparum. Much more than 200 million folks get malaria every year and much more than half a million of people, mainly children, die from the condition.


The fast development in population movements meant there was a danger resistant malaria may well attain other countries a lot more speedily, Gilson mentioned. Although resistant malaria is not unattainable to treat, it requires a whole lot longer.



Breakthrough produced in quest for new malaria medicines as resistance fears expand

7 Temmuz 2014 Pazartesi

Controversial Trial Finds No Benefit For Pricey Medicines Firm Drug

Even though there is broad consensus in the health-related neighborhood that principal PCI is the ideal remedy for heart assault patients when it can be delivered promptly, there is no agreement about the greatest accompanying drug routine, which normally entails a blend of antiplatelet and antithrombotic medication. The part of one particular antithrombotic, bivalirudin (Angiomax, The Medicines Firm) has been notably uncertain since it is far much more costly than its alternative, unfractionated heparin.


HEAT-PPCI was made to aid settle this dilemma. The investigators ran a large, sensible clinical trial that instantly randomized all main PCI sufferers at the Liverpool Heart and Chest Hospital in the Uk. The outcomes of the trial, which have been the topic of considerable debate when they had been presented at the American College of Cardiology meeting earlier this yr, have now been published in the Lancet, along with two editorials that tackle the controversies engendered by the trial.


one,829 sufferers have been randomized in the HEAT-PPCI trial to either heparin or bivalirudin. The final results did not show any advantage for bivalirudin.  There was a considerable increase in the principal efficacy outcome– a composite of death, stroke, reinfarction, or unplanned target lesion revascularization– in the bivalirudin group compared with the heparin group (8.seven% versus 5.7%, RR one.53, CI 1.09-two.13, p=.01). There was no significant distinction in the incidence of major bleeding (3.5% versus three.one%, p-.59). The use of bailout GP IIb/IIIa inhibitors was comparable in both groups: 13% for bivalirudin and 15% for heparin.


The authors conclude that their trial “suggests that the use of heparin, rather than bivalirudin confers substantial benefit in the avoidance of major adverse occasions. This locating may well give an possibility, uncommon in modern day overall health care, to give improved outcomes at much diminished price. In our centre, routine use of heparin (rather than bivalirudin, which fees about 400 occasions as a lot) would reduce quick drug costs in our yearly 1000 PPCI instances by £500 000.”


In an accompanying editorial, Peter Berger and James Blankenship say that the distinction in findings among HEAT-PPCI and earlier trials can be explained by many factors, such as the lower use of GP IIb/IIIa inhibitor in conjunction with heparin in HEAT-PPCI, the use of greater doses of heparin in earlier studies, and the better use of radial access in HEAT-PPCI. The trial, they compose, “provides strong proof that bivalirudin alone compared with 70 U/kg of heparin alone (with infrequent bailout use of GP IIb/IIIA inhibitors in each arms), with radial entry for STEMI percutaneous coronary intervention, seems to be inferior to heparin as administered in this trial. Even if heparin alone had produced statistically similar outcomes to bivalirudin, it would have been a win for heparin. A drug that charges significantly less than a 400th of an additional that has comparable efficacy and safety ought be utilised preferentially.”


In a second editorial David Shaw dismisses the intense criticism from some prominent critics of the trial’s ethics based on the truth that trial participants did not offer informed consent till following they had been randomized. Rather, he writes, “HEAT-PPCI is not only an extraordinary achievement in medical analysis, but also in ethical study style. Far from becoming unethical, the research sets a large standard for consent in pragmatic trials.”


Delayed consent “was preferable to attempting to acquire consent from potentially incompetent individuals needing really urgent cardiac treatment… The use of delayed consent is specifically appropriate in pragmatic comparative effectiveness trials the place the two medicines below investigation are each used for licensed indications in problems of equipoise. In regimen clinical care, it would be completely standard for a physician to select either heparin or bilvalirudin with no involvement of the patient in the determination.”


The results of the trial also “mean that assets will not be wasted on bivalirudin, a much more pricey and much less successful treatment than heparin.” Shaw observes: “Unsurprisingly, significantly of the opposition to HEAT-PPCI has come from medical professionals with shut industry ties.”



Controversial Trial Finds No Benefit For Pricey Medicines Firm Drug

18 Haziran 2014 Çarşamba

Dementia sufferers ought to be provided the very best medicines, says David Cameron

Individuals in their 40s nowadays would then be spared establishing the ailment.


Mr Cameron would like public paying on dementia drug investigation to double from £66  million in 2015 to £122 million in 2015. He will write to the leaders of other superior nations urging them to match that dedication.


He is also searching for approaches to inspire private sector investment in the industry.


He will inform the pharmaceutical sector that the “status quo is not very good enough”. Enterprise and governments must accelerate progress on developing new drugs.


The Globe Health Organisation forecasts that the numbers of dementia suffers will double worldwide each and every two decades.


Even so, global spending on dementia is five times under that spent on cancer due to a “market failure” in dementia study and drug development.


Only three new medicines have been put on the industry in the past 15 many years.


Medicines that delay the onset of dementia by three many years would conserve Britain £5  billion a year in treatment method and financial output, ministers feel. Mr Cameron will tell the healthcare summit right now: “The reality is that dementia now stands alongside cancer as a single of the greatest enemies of humanity.


“We have to fight to remedy it. I know some people will say that it’s not achievable, but we have witnessed with cancer what medicine can accomplish. We initial need to have to tackle head-on the marketplace failure perilously undermining dementia investigation and drug improvement.


“And we want investment in research, higher collaboration, much better incentives for taking new treatments to market place and earlier access to progressive new treatments. We need to have to join up the dots and create a huge, bold global push to beat this. It will consider years of function but we have shown with other conditions that we can make progress and we will do so again.”


Dr Dennis Gillings, who has been appointed the Planet Dementia Envoy by the Prime Minister, will tell the summit that progress has been “achingly slow” and “radical change” is necessary.


He will say: “Just as the world came with each other in the battle towards HIV/Aids, we need to cost-free up regulation so that we can check ground-breaking new medicines, and examine regardless of whether the time period for industry exclusivity could be extended.”



Dementia sufferers ought to be provided the very best medicines, says David Cameron

13 Haziran 2014 Cuma

Underneath Obamacare"s "Closed Formularies" Sufferers With Serious Persistent Illnesses like MS Will not Get Access to Crucial Medicines

Americans who signal up for insurance under Obamacare are discovering many of these strategies offer you very narrow choices when it comes to their option of medical doctors and medication.


Some argue these narrow benefit styles aren’t unique to Obamacare. But this is not fully correct. The construction of the exchanges pre-ordained the wider adoption of these restrictive networks and formularies, and certainly produced these constructs politically appropriate.


Because many ideas have tiny or no co-insurance outdoors of their networks and formularies, sufferers seeking care outdoors of these narrow arrangements can be saddled with the complete price of these options. Under a lot of programs, when patients are out of their networks or off their drug formularies, these charges don’t count against deductibles or out of pocket maximums.


To get a sense of how restrictive the formularies are, and its affect on sufferers, we looked at medicines utilized to deal with two various continual diseases, rheumatoid arthritis and several sclerosis.


We examined the drug coverage presented by reduced price silver wellness plans presented in the most populated counties in ten different states, and focused on ten disease-modifying drugs that are broadly prescribed for these sufferers. We located that none of the programs offered coverage for all of the medicines, or covered any of them with out important cost sharing that would tap out most peoples’ yearly deductibles and out-of-pocket limits on investing.


The challenge for consumers is that most of the plans have “closed” formularies exactly where non-formulary medication are not covered. Additionally, the cap on out of pocket spending only applies to fees incurred on drugs incorporated on a plan’s formulary. That signifies that individuals could be saddled with the complete price of several of these medication, with no limits on that paying.


Amid some our findings, the several sclerosis drug Aubagio was left off the closed formularies of two of ten programs. So patients on these plans could have to shell out the full $ four,420 month-to-month retail price of this medication, translating to about $ 53,000 yearly. The drug Avonex left off the formularies of two of the ten programs, probably saddling patients with the drug’s $ 4,805 regular monthly price ($ 57,660 annually). Extavia wasn’t included on two of 10 formularies, at a month-to-month price of $ four,625 ($ 55,500 annually). Tecfidera was left off 6 of the 10 strategies at a monthly cost to sufferers of $ 5,209 (at a total value of $ 62,508 yearly).


We identified equivalent final results when it came to drugs targeted to the remedy of rheumatoid arthritis. The RA drug Xeljanz wasn’t integrated on the closed formularies of 4 of the 10 plans we examined at a month to month expense to the patient of $ 2,485, or $ 29,820 annually. Orencia was left off two strategies ($ 2,673 a month, or $ 32,076 annually) and Kineret wasn’t included in two ideas (at a cost of $ 2,978 a month, or $ 35,736 annually).


The RA drug Remicade was left off the formulary of 3 programs (about $ 3,592 for a two-month provide, or $ 21,552 yearly). Rituxan was left off of six ideas (a course of therapy will expense about $ two,868). Even though Actemra was left off four programs (about $ 1,555 each two weeks for a bi-weekly course of treatment, or $ 37,320 yearly). Simponi was left off two programs (at a expense of about $ 2,867 for a 1-month 50mg supply, or $ 34,404 yearly).


The high cost of developing innovative medicines translates into substantial retail prices. This is a challenge for our healthcare technique. But the value of illness progression, and the ensuing disability, can far outweigh the value of effective management with some of these medicines. Several newer medicines are much more targeted to these diseases, and far far more effective.


These findings have been replicated by other analyses. 1 examine by Avalere Well being of 22 carriers in six states located that the number of medication accessible on formularies ranged from a reduced of about 480 to nearly 1,110. Even if your drug makes it onto the plan’s formulary, receiving entry can even now be a costly affair. An additional evaluation launched this week looked at 123 formularies from various exchange strategies. It identified that a lot more than a single-fifth of silver programs demand co-insurance of forty% or far more for drugs for 1 of seven diverse continual conditions. About thirty% of programs provided no coverage for at least a single key drug for multiple sclerosis.


The identical issues are getting witnessed when it comes to the networks of medical doctors that the well being ideas supply. Much more than two-thirds of exchange strategies have assembled supplier networks regarded “narrow” or “ultra-narrow,” in which as many as 70% of hospitals and other local well being companies are not included. Earlier this year, we launched an examination on these networks that consistently found that exchange strategies offered just a fraction of the professionals available in the PPO strategy offered by the same carrier and provided in the exact same area.


In the 1990s, buyers firmly rejected the idea of extremely restrictive wellness strategies and drug formularies when they spurned HMOs in favor of Favored Provider Organizations. Nevertheless the ACA is premised on a see that consumers had been making a undesirable trade. The ACA effectively codifies the HMO model into law – forcing customers into restrictive networks and formularies as a way to shell out for the charges of Obamacare’s mandated positive aspects.


Congress could reform Obamacare by permitting any wellness plan that previously met state eligibility (prior to Obamacare) to be presented on the exchanges. This would permit for a significantly wider variety of ideas that make diverse tradeoffs amongst benefit style and networks. The restrictive schemes are an unfortunate consequence of the way that Obamacare structured the state exchanges. It is inside of Congress’ power to correct these guidelines.


You can follow Dr. Scott Gottlieb on Twitter @ScottGottliebMD



Underneath Obamacare"s "Closed Formularies" Sufferers With Serious Persistent Illnesses like MS Will not Get Access to Crucial Medicines

12 Haziran 2014 Perşembe

Sharp Scrutiny From European Medicines Company Of Amgen And Servier Heart Drug

There could be difficulty on the horizon for ivabradine, a heart drug marketed by Servier beneath the brand names of Corlentor and Procoralan. The drug is extensively available in Europe and elsewhere, even though it is not offered in the US, exactly where it is underneath growth by Amgen. Even though it hasn’t been widely noticed– I can discover no other press reports– the European Medicines Agency explained that it has started a assessment of the drug based mostly on troubling findings from the SIGNIFY research. (Ivabradine is employed to treat sufferers with lengthy-term steady angina and extended-phrase heart failure.)


The main results of SIGNIFY are scheduled to be presented on August 31 at the European Society of Cardiology meeting in Barcelona. But on May possibly eight the European Medicines Agency announced that it had initiated a assessment of ivabradine based mostly on  preliminary benefits:



The evaluation follows preliminary final results from the SIGNIFY study, which was evaluating whether treatment method with Corlentor/Procoralan in individuals with coronary heart disease reduces the fee of cardiovascular occasions (such as heart attack) when compared with placebo (a dummy therapy). Individuals in the study received up to 10 mg twice every day, which is greater than the at the moment authorised optimum everyday dose (7.five mg twice everyday), and the final results showed a little but significant increase in the combined danger of cardiovascular death or non-fatal heart assault with the medication in a subgroup of individuals who had symptomatic angina (Canadian Cardiovascular Society class II – IV).


The European Medicines Company will now evaluate the influence of the data from the SIGNIFY study on the balance of rewards and risks of Corlentor/Procoralan and situation an opinion on whether the advertising and marketing authorisation ought to be maintained, varied, suspended or withdrawn across the EU.



Ivabradine slows the rate of the heart by inhibiting the so-called “funny” current inside of the heart’s natural pacemaker, the sinoatrial node.


It must be mentioned that Amgen recently announced that the FDA had granted rapidly track standing to the drug. But it should also be mentioned that every single FDA skilled with whom I’ve spoken has said that the fast track designation indicates definitely nothing (even though in my encounter it’s almost always a good excuse for a business to issue a press release).


Update: In a statement Amgen said that it planned to submit the FDA filing for ivabradine for individuals with chronic heart failure. The SIGNIFY trial included sufferers with continual stable coronary artery illness without having heart failure.



Sharp Scrutiny From European Medicines Company Of Amgen And Servier Heart Drug

4 Haziran 2014 Çarşamba

Fast Path For Breast Cancer Medicines Want Not Be Blocked, Leading Statistician Says

In excess of the weekend, a clinical trial result was launched that could not only impact one particular company and group of sufferers, but any energy to produce a new drug in breast cancer.


A review funded by GlaxoSmithkline of its cancer pill Tykerb failed to show that including Tykerb to the drug Herceptin could lengthen survival compared to Herceptin alone in ladies who had their tumors surgically removed. A previous research showed incorporating Tykerb to Herceptin enhanced the odds of a tumor shrinking or disappearing just before surgical treatment. (Tykerb is getting sold to Novartis Novartis along with Glaxo’s other marketed cancer medication.)


The discrepancy is a large deal since the 2nd sort of research is witnessed as possible substitute for huge, submit-surgical procedure scientific studies in approving new drugs. The problem is that the post-surgical treatment research are getting to be so large as to be challenging to conduct. The FDA has currently authorized a single drug, Roche’s Perjeta, based mostly on that sort of information. “If the question is can we routinely use the preoperative setting as a reliable test, the reply is perhaps not,” stated Clifford Hudis, past-president of the American Society of Clinical Oncology (ASCO) and an oncologist at Memorial Sloan-Kettering Cancer Center Memorial Sloan-Kettering Cancer Center.


The news of Tykerb’s failure hit a single biotechnology organization, Puma Biotechnology Puma Biotechnology, particularly difficult. Shares of Puma have fallen 27% since the data have been presented at the ASCO meeting. Puma has benefited as a outcome of a government-funded examine, named I-SPY two, which tests numerous medication in the neoadjuvant setting using newer statistical strategies. Puma’s drug, neratinib, graduated from the research since I-SPY two predicted there is a 72% probability it will be successful in a larger phase III trial. http://www.pumabiotechnology.com/pr20131204.html


So if the total thought of translating information from the pre-surgical procedure (also known as neoadjuvant) to submit-surgical treatment (referred to as adjuvant) setting is untenable, that’s certainly negative for Puma and a great deal of other drug companies.


But Donald Berry of M.D. Anderson Cancer Center, the statistician who created the I-SPY two trial, says there is no difficulty at all, because there was no disagreement between the previous Tykerb research, known as Neo-ALTTO, and the new one particular, called ALTTO. He writes via e mail that the results from ALTTO are precisely what you’d assume from the earlier examine – ALTTO wasn’t large sufficient, and the result was also little, for it to attain statistical significance. Officials at the Foods and Drug Administration were cc’d on the e mail.


Berry writes:



The easy and clear mathematical fact is that the final results of NeoALTTO and ALTTO are amazingly consistent. Taking into consideration NeoALTTO by itself, the pCR (in each breast and axilla) benefit of trastuzumab plus lapatinib in excess of trastuzumab without lapatinib is twenty%, with a self confidence interval of about 10% to 30%. Assuming the EFS outcomes from the FDA’s metaanalysis (Cortazar et al.) for HER2-constructive disease, the expected hazard ratio of EFS derived from a pCR advantage of twenty% is .83, virtually specifically the real hazard ratio in ALTTO of .84 (the latter with a self-confidence interval from .70 to 1.02).


Furthermore, there are 5 randomized trials that evaluated trastuzumab +/- lapatinib in the neoadjuvant setting (which includes NeoALTTO), with a complete of in excess of 1200 sufferers. The general advantage of the blend in these 5 trials was 13%. The EFS hazard ratio corresponding to a 13% pCR advantage in HER2-optimistic ailment is .88. So the benefits of ALTTO with its hazard ratio of .84 are in fact relatively a lot more constructive than the FDA’s metaanalysis would predict on the basis of the accessible neoadjuvant data.


A lesson here might be that statistical significance does not imply reality and lack of statistical significance does not imply falsity.



…


That squares effectively with remarks created by Richard Pazdur, who heads the FDA’s oncology drugs division. He told me in an interview that the FDA doesn’t yet know how to use data from the neoadjuvant research, but that it is thinking about the totality of data on medication that look for approval based mostly on them. For now, the FDA’s policies are not changing as it evaluates the scientific studies, and he says that other data helped it feel certain about approving Perjeta.


Puma Biotechnology, the principal stock in perform above all this, does have other concerns. Information presented the two at the American Association for Cancer Research earlier this year and at ASCO present quite high prices of diarrhea with the drug — greater than 50% when diarrhea medicines were not offered prophylactically, and 30% when they have been. Some investors have been disappointed with its efficacy as properly. Sufferers whose cancer had spread to the brain who took neratinib saw their disease worsen in a median of one.9 months. Three of forty sufferers saw their ailment shrink, and in 4 sufferers the tumors remained the identical size.



Fast Path For Breast Cancer Medicines Want Not Be Blocked, Leading Statistician Says

30 Mayıs 2014 Cuma

Benefits of statins outweigh hazards, says medicines regulator

Statin pills

Statin tablets. Photograph: Alamy




Millions of people prescribed cholesterol-lowering statins must carry on to get them because the rewards outweigh the risks, Britain’s medicines regulator stated on Friday. The Medicines and Healthcare items Regulatory Company (MHRA) issued a safety update following a row above the frequency of side results from the drugs. It mentioned evidence from large clinical trials showed statins could conserve lives by reducing the chance of heart attacks, strokes and the want for heart surgery.


Its tips to overall health professionals explained at least 450 deaths from heart attacks, stroke or vascular failure would be prevented for each and every 10,000 sufferers taken care of, if patients with a 20% risk or a lot more of suffering such a cardiovascular occasion over a 10-12 months time period took statins for at least five many years.


The update came soon after the British Health care Journal(BMJ) commissioned an independent panel to report on how claims that 18-20% of people on statins suffered adverse occasions were published in the journal last year .


The verdict is anticipated by the end of July. The authors of two articles making use of the figure, John Abramson, from Harvard health-related college, and Aseem Malhotra, a United kingdom cardiologist, have withdrawn statements on the frequency of side effects following a charge from Prof Sir Rory Collins of Oxford University that the information was inaccurate and could endanger lives.


Collins, a foremost advocate of statins, has argued that both articles ought to be withdrawn completely, saying they had caused uncertainty in patients. He recommended they could lead to far much more harm than the scare over the MMR vaccine induced by the now discredited Andrew Wakefield.


Statins are currently currently being taken in Britain by about seven million individuals who have at least a 20% risk of a heart attack or stroke in the up coming ten years. The National Institute for Overall health and Care Excellence (Wonderful) recommended in February that statins ought to be given to people at only ten% risk – a move that could significantly boost the number of individuals taking them.


The five kinds of statin prescribed in Britain are taken when a day, often final issue at evening, and most individuals will get them for the rest of their lives. They can interact with other medicines.


The MHRA’s new overview of evidence recognises statins, “like all medicines”, can result in side results in some people – mainly mild and most often muscle-related – but says most people need to carry on to consider the medication.


It reminds prescribers to advise patients to look for prompt health-related interest if they experience muscle troubles while on the medicines. For some patients stopping statin remedy may be acceptable. If statin treatment method should be continued despite the muscle issues, prescribers need to consider making use of a lower statin dose or switching to a diverse statin, the tips says.


“The rewards of making use of any statin in its licensed indication outweigh the hazards in most sufferers”, it says. But the “possible benefits and harms” must be regarded in each situation.


June Raine, MHRA’s director of vigilance and risk management of medicines, mentioned: “The MHRA continually testimonials the details on the safety of statins. We will update the prescribing guidance for statins in light of any substantial new proof of safety issues. If individuals have any issues about their medicines then they should talk to their medical professional.


“If you believe you have suffered a side-result to any medicine, please tell us about it by means of our Yellow Card scheme at www.yellowcard.mhra.gov.uk.”




Benefits of statins outweigh hazards, says medicines regulator

22 Mayıs 2014 Perşembe

NHS medication raid finds medicines diverted into blackmarket: regulator

It is feared the company was set up and a NHS licence obtained purely to siphon off medication.


The medicines regulator seized far more than £700,000 worth of medicines, such as £160,000 well worth of diazepam, a effective managed drug for anxiousness.


Two guys had been arrested.


The arrests came as part of Operation Pangaea, an international programme involving 101 nations and coordinated by Interpol which saw approximately 3.6 million doses of medication, really worth all around £9.5 million, seized in Britain this yr.


Danny Lee-Frost, head of operations at the MHRA, mentioned that numerous prescription-only drugs had likely to lead to severe harm if they are not administered appropriately or if appropriate checks are not produced to guarantee there are no allergies or interactions with other medicines.


Even though there is no suggestion the men arrested had tampered with the drugs, or that they have been counterfeit, aathere was clear evidence they had not been stored beneath right conditions.


“These wholesalers had a licence to sell to medical professionals and pharmacies but they are not licensed to promote to any previous member of the public,” mentioned Mr Lee-Frost.


“By marketing prescription-only medicines in this way it signifies that potentially unsafe products are acquiring out into the public.


“The licence that a wholesaler has comes with a whole raft of laws to make positive that the product can’t be contaminated or deteriorate, is stored at the appropriate temperature and not near a window or a hot radiator, for illustration.


“But if the drug is not in the right hands, you just really do not know what condition it is in before it ends up in a patient.”


He extra: “The drug could also be offered to a person who shouldn’t be obtaining it on the advice of a physician simply because of the side effects or simply because it could interfere with other medicine they are taking.


“It’s no shock these people finish up in casualty.”


Investigations revealed the wholesaler was largely supplying diazepam, a extremely addictive pill for anxiety and anxiousness disorders and one of the most typically misused prescription drugs. Each and every pill has a street value of about £1.


Other medication seized in a raid on the wholesale deal with incorporate items for erectile dysfunction, insomnia, antidepressants, breast cancer, hypertension, hair reduction, cholesterol, and gout. They have a complete worth of £755,211.


The guys had been arrested below the Misuse of Medicines Act and have now been bailed to reappear.


The operation also targeted 10,603 web sites that were illegally marketing counterfeit and unlicensed medicines and led to them currently being closed down or suspended by means of getting their domain name or payment facility removal.


They seized three.6 million doses of counterfeit and unlicensed medicines, 5 arrests and the shutdown of 1,891 sites.


The regulators mentioned blackmarket sellers were more and more turning to social media and YouTube to spot adverts for their companies and are utilizing sites hosted abroad in an attempt to evade detection.


You Tube accounts had been targeted for the initial time and 18,671 video clips were eliminated in the past 12 months.


Alastair Jeffrey, head of enforcement at the MHRA, mentioned: “Operation Pangaea’ is the international response to World wide web facilitated medicines crime. Throughout a week of action we have seized £8.6 million well worth of counterfeit and unlicensed medicines, shut down 1,891 websites working illegally and removed nearly twenty,000 links to these sites that were supported by social media platforms.


“We have conducted raids across the country, making 5 arrests. The medicines recovered during these raids have been being held in appalling situations, such as a dirty previous developing with broken windows, with medicines lying on the floor in bin bags.


Criminals involved in the unlawful provide of medicines by means of the World wide web aren’t interested in your well being they are interested in your cash. Whether they get this by means of selling you a potentially unsafe counterfeit or unlicensed drug or via stealing your bank specifics. To shield your overall health, check out your GP, get a right diagnosis and buy medicines from a genuine substantial street or online pharmacy.”


Ria Baxendale, from Border Force’s postal command, explained: “Our involvement in this joint operation demonstrates our dedication to tackling the smuggling of fake and unlicensed medicines. These products can be hazardous and individuals who revenue from this unlawful trade are often involved in other kinds of serious organised crime.


“My message to the public is basic – don’t acquire anything on the internet except if you are certain it comes from a genuine manufacturer.”


Dr Rick Grenville, director of the Association of the British Pharmaceutical Sector, stated: “The ABPI welcomes this crackdown on potentially damaging counterfeit medicines from getting sourced through the net.


“In the potential we seem forward to functioning with the MHRA and other United kingdom stakeholders to maximise the security features linked with the European Falsified Medicines Directive and to minimise any threat of corruption of the NHS supply chain.”


A tandem operation was co-ordinated by the American Foods and Drug Administration.



NHS medication raid finds medicines diverted into blackmarket: regulator

30 Nisan 2014 Çarşamba

Psychiatric medicines are performing us much more harm than excellent | Peter Gøtzsche

‘More than 53m prescriptions for antidepressants have been issued in 2013 in England alone.’ Photograph: travel-and-far more/Alamy




We appear to be in the midst of a psychiatric drug epidemic, just as we have been when benzodiazepines (tranquilisers) had been at their height in the late 1980s. The decline in their use right after warnings about addiction led to a large boost in the use of the newer antidepressants, the SSRIs (selective serotonin re-uptake inhibitors).


Figures released by the Council for Proof-based mostly Psychiatry, which was set up to challenge a lot of of the assumptions commonly manufactured about contemporary psychiatry, show that much more than 53m prescriptions for antidepressants have been issued in 2013 in England alone. This is nearly the equivalent of a single for every guy, woman and little one and constitutes a 92% enhance since 2003.


Revenue of antidepressants have skyrocketed everywhere and are now so substantial in my very own country, Denmark, that – if the prescriptions were equally distributed – every single citizen could be in therapy for six many years of their existence. The predicament is even worse in the US, in which direct promoting of prescription medication to the public is permitted and in which more psychiatrists had been “educated” with sector hospitality than any other health-related discipline.


I began to realise the scale of the dilemma when I was persuaded seven many years ago to grow to be a tutor for a PhD thesis on no matter whether history was repeating itself, by evaluating benzodiazepines (“mother’s little helper”) with SSRIs. This study has established that people get as hooked on SSRIs as they did on benzodiazepines, and 37 of 42 withdrawal symptoms were the same for SSRIs as for benzodiazepines.


It is challenging to think that so a lot of individuals have become mentally disturbed and that these prescription increases reflect a genuine need, so we require to look for other explanations. There look to be three principal reasons for the huge development.


Initial, the definitions of psychiatric ailments are so vague that several healthy individuals can be diagnosed inappropriately. Second, some of the psychiatrists who wrote the diagnostic manuals have been on the industry’s payroll, and this might have also led to significant diagnostic inflation. Third, the companies’ behaviour has been worse in psychiatry than in any other spot of medication, with billion-dollar fines paid for the unlawful advertising of psychiatric drugs for non-approved uses. The rise in sales reflects patient dependency on these SSRIs: they may possibly have excellent trouble stopping even when they taper off the drugs slowly. Withdrawal signs are typically misdiagnosed as a return of the disease or the commence of a new one particular, for which medication are then prescribed. More than time, this prospects to an boost in the number of drug-dependent, lengthy-term users.


One more significant difficulty with psychiatric medication is that they can trigger the signs they are supposed to alleviate. Unfortunately, psychiatrists tend to boost the dose or include another drug when a patient reports damaging effects.


The problem is that many of these medication just do not perform as individuals suppose. The main result of antidepressants is not the reduction of depressive symptoms. They are no much better than placebo for mild depression, only somewhat greater for moderate depression, and advantage only a single out of 10 with serious depression. In all around half of all patients, they trigger sexual disturbances. The signs consist of decreased libido, delayed orgasm or ejaculation, no orgasm or ejaculation and erectile dysfunction. Studies in the two people and animals recommend that these effects may persist long after the drug has been discontinued.


The US Foods and Drug Administration has shown that antidepressants boost suicidal behaviour up to the age of forty, and numerous suicides have been reported even in wholesome people who took the medication for other reasons (for example, for tension or soreness). The identical report also said that, among individuals above 65 who are taken care of for one year, antidepressants are believed to destroy a single out of every single 28, because they lead to falls and hip fractures. Indeed, it is not clear whether antidepressants are protected at any age.


My studies of the research literature in this complete spot lead me to a extremely uncomfortable conclusion: the way we at present use psychiatric medication is creating much more harm than excellent. We ought to as a result use them significantly less, for shorter intervals of time, and often with a prepare for tapering off, to stop men and women from becoming medicated for the rest of their lives.




Psychiatric medicines are performing us much more harm than excellent | Peter Gøtzsche

28 Nisan 2014 Pazartesi

Massive pharma"s ransom for new medicines | @guardianletters

Watchdog blocks breast cancer drug

Kadcyla, a new drug for breast cancer, is to be blocked from program NHS access beneath draft advice issued by the National Institute for Wellness and Care Excellence (Good). Photograph: Rui Vieira/PA




In a statement issued by Roche and cited in your post (Nice rejects new breast cancer drug as also costly, 23 April), Professor Paul Ellis attempts to justify the £90,000-per-patient price of the cancer drug Kadcyla, insisting that it gives sufferers with useful additional time with their loved ones – “time that you are not able to put a price tag on”. I agree that you can’t put a value tag on a terminally ill person’s remaining months. But with Kadcyla’s £90,000 value tag, has not Roche completed just that?


New medicines can lessen patients’ side effects and prolong their lives. Indeed, considering the toxic regimens that medical doctors still have to use to deal with conditions like cancer and tuberculosis, it is clear that we require new treatment options. But what use is innovation if individuals can not entry these new medication because they are as well pricey? This has been a recognised problem in reduced- and middle-cash flow countries for some time. But increasingly individuals in countries like the United kingdom are locating they or their wellness programs can’t afford these charges both.


We’re told that if we don’t permit firms to charge enormous sums for medicines, then they can’t fund the research and advancement (R&ampD) essential to produce much more new medicines. But retail prices do not reflect the price of manufacturing – in truth, the price of producing a drug will be just a tiny fraction of what it goes for on the marketplace. Retail prices are set in accordance to the highest amount a industry will bear in the absence of price tag-reducing competitors.


Why do we proceed to accept a method the place, with no transparency on the expense of R&ampD, firms are allowed to promote new drugs under monopoly conditions and set their personal pricing, effectively holding governments and individuals to ransom? Eventually, we require to find a way to pay out for the growth of new medicines that isn’t going to put all the bargaining chips in pharma companies’ hands. It’s achievable, but to get there we need to have our governments to look at option organization versions that reward the development of new drugs without having conferring monopolies.


The system is broken and we require to resolve it, urgently. Time is passing and, clearly, it comes at a price.
Katy Athersuch
Access campaign, Médecins Sans Frontières/Doctors Without having Borders (MSF)




Massive pharma"s ransom for new medicines | @guardianletters

25 Nisan 2014 Cuma

Heartburn drug Motilium must be restricted due to heart deaths, says medicines regulator


Around two million individuals have been prescribed Motilium, also recognized as domperidone, for sickness and nausea symptoms, abdomen situations and heartburn. Now following a evaluation at European degree, the drug will be limited for individuals with sickness and nausea only.




The drug is widely prescribed by GPs for infants with extreme reflux and can continue to be utilized in this way underneath caution and when the physician has carefully calculated the dose according to the child’s fat and is happy they do not have a heart condition, a spokesman for the medication regulator mentioned.




Dr Sarah Branch, deputy director of the MHRA’s Vigilance and Risk Management of Medicines Division, mentioned: “This assessment looked at the available information in depth.




“It concluded that the benefits outweigh the risks of employing domperidone when utilised to treat nausea and vomiting but that there should be restrictions on its use. It should no longer be used for signs of stomach discomfort such as heartburn and feelings of fullness.


“There is no require to cease taking your medicine. However, if you have an underlying heart issue or have any other queries, please speak to your physician or pharmacist at your up coming program go to.


“If you have seasoned any side effects to this medication you can report these to us at: www.mhra.gov.uk/yellowcard.”


The drug ought to be utilised at the lowest successful dose for the shortest time period of time attainable and not longer than a week.


The injectable kind of the drug was withdrawn in 1985 because of this kind of side results.


Critical effects on the heart with domperidone incorporate disturbance to the rhythm and electrical activity of the organ.




Heartburn drug Motilium must be restricted due to heart deaths, says medicines regulator

Well-liked heartburn drug Motilium need to be restricted due to heart deaths: medicines regulator


The drug is extensively prescribed by GPs for babies with serious reflux and can continue to be used in this way under caution and when the doctor has very carefully calculated the dose according to the child’s weight and is satisfied they do not have a heart problem, a spokesman for the drugs regulator mentioned.




Dr Sarah Branch, Deputy Director of the MHRA’s Vigilance and Danger Management of Medicines Division, explained: “This review looked at the obtainable information in depth.


“It concluded that the positive aspects outweigh the dangers of utilizing domperidone when utilised to treat nausea and vomiting but that there must be restrictions on its use. It should no longer be utilised for signs and symptoms of abdominal discomfort such as heartburn and emotions of fullness.


“There is no need to end taking your medicine. Even so, if you have an underlying heart situation or have any other questions, please communicate to your medical professional or pharmacist at your next schedule pay a visit to.


“If you have seasoned any side effects to this medicine you can report these to us at: www.mhra.gov.uk/yellowcard.”


The drug must be utilised at the lowest efficient dose for the shortest period of time achievable and not longer than a week.


The injectable type of the drug was withdrawn in 1985 due to the fact of such side effects.


Significant results on the heart with domperidone contain disturbance to the rhythm and electrical exercise of the organ.




Well-liked heartburn drug Motilium need to be restricted due to heart deaths: medicines regulator